NCT00136864View on ClinicalTrials.gov

Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)

PHASE3CompletedINTERVENTIONAL
Enrollment

310

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

November 30, 2009

Study Completion Date

September 30, 2011

Conditions
Non-Small-Cell Lung Carcinoma
Interventions
PROCEDURE

PET Diagnostic Imaging

Patients in the PET group will undergo the standard diagnostic tests plus PET to determine those suitable for combined modality therapy

Trial Locations (5)

L8V 5C2

Juravinski Cancer Centre, Hamilton

N6A 4L6

London Regional Cancer Centre, London

K1H 1C4

Ottawa Hospital Regional Cancer Centre, Ottawa

M4N 3M5

Toronto-Sunnybrook Odette Regional Cancer Centre, Toronto

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

Ontario Ministry of Health and Long Term Care

OTHER_GOV

lead

Ontario Clinical Oncology Group (OCOG)

OTHER

NCT00136864 - Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial) | Biotech Hunter | Biotech Hunter